DK1014996T3 - Præparater indeholdende saccharid til behandling af Alzheimers sygdom og andre amyloidoser - Google Patents

Præparater indeholdende saccharid til behandling af Alzheimers sygdom og andre amyloidoser

Info

Publication number
DK1014996T3
DK1014996T3 DK98943468T DK98943468T DK1014996T3 DK 1014996 T3 DK1014996 T3 DK 1014996T3 DK 98943468 T DK98943468 T DK 98943468T DK 98943468 T DK98943468 T DK 98943468T DK 1014996 T3 DK1014996 T3 DK 1014996T3
Authority
DK
Denmark
Prior art keywords
disease
alzheimer
amyloidoses
treatment
preparations containing
Prior art date
Application number
DK98943468T
Other languages
Danish (da)
English (en)
Inventor
Gerardo Castillo
Alan D Snow
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of DK1014996T3 publication Critical patent/DK1014996T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
DK98943468T 1997-08-28 1998-08-28 Præparater indeholdende saccharid til behandling af Alzheimers sygdom og andre amyloidoser DK1014996T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5714497P 1997-08-28 1997-08-28
PCT/US1998/017952 WO1999009999A1 (en) 1997-08-28 1998-08-28 Specific saccharide compositions and methods for treating alzheimer's disease and other amyloidoses

Publications (1)

Publication Number Publication Date
DK1014996T3 true DK1014996T3 (da) 2003-09-29

Family

ID=22008776

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98943468T DK1014996T3 (da) 1997-08-28 1998-08-28 Præparater indeholdende saccharid til behandling af Alzheimers sygdom og andre amyloidoser

Country Status (10)

Country Link
US (1) US6037327A (de)
EP (1) EP1014996B1 (de)
JP (1) JP4659209B2 (de)
AT (1) ATE241365T1 (de)
AU (1) AU9125798A (de)
CA (1) CA2301725C (de)
DE (1) DE69815122T2 (de)
DK (1) DK1014996T3 (de)
ES (1) ES2200366T3 (de)
WO (1) WO1999009999A1 (de)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030017998A1 (en) * 1997-05-16 2003-01-23 Snow Alan D. Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases
EP0899957A1 (de) * 1997-08-27 1999-03-03 Koninklijke Philips Electronics N.V. Vorrichtung zur drahtlosen Verbreitung von Fernsehsignalen in einer Wohnung
EP0902083B1 (de) * 1997-09-09 2004-10-13 Ciba SC Holding AG Verfahren zur Gewebepflege
US6114405A (en) * 1997-10-09 2000-09-05 Research Frontiers Incorporated Ultraviolet radiation-curable light-modulating film for a light valve, and method of making same
BE1011535A3 (nl) * 1997-11-05 1999-10-05 Framatome Connectors Belgium Werkwijze en inrichting voor het opmeten van de positie van een reeks contactpennen en voor het aanbrengen van deze reeks in een plaat met gedrukte schakelingen.
GB2332314B (en) * 1997-12-09 2001-05-16 Sony Uk Ltd Interface for a receiver and method of arrangement thereof
KR100552914B1 (ko) * 1998-07-10 2006-06-28 제일모직주식회사 칼러레지스트수지조성물
KR20000014564A (ko) * 1998-08-21 2000-03-15 윤종용 통합 메시징 시스템의 수신 팩스 데이터 편집 및 재전송방법
US6767898B2 (en) * 1998-08-28 2004-07-27 University Of Washington Methods for using specific saccharides for treating alzheimer's disease and other amyloidoses
KR100389295B1 (ko) * 1998-09-28 2003-12-18 에스케이씨 주식회사 폴리에스테르필름및그제조방법
KR100548233B1 (ko) * 1998-12-15 2006-05-09 엘지전자 주식회사 네트워크를 이용한 양방향 방송 시스템
KR100593996B1 (ko) * 1998-12-17 2006-09-27 삼성전자주식회사 휴대폰에서의 배경화면 디스플레이방법
US6562836B1 (en) * 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
US6159986A (en) * 1999-11-02 2000-12-12 Altman; David A. Compounds and therapy for resisting memory loss in humans
US6689753B1 (en) * 1999-11-05 2004-02-10 Axonyx, Inc. β sheet breaker peptide analogs that inhibit β pleated sheet formation in amyloid β-peptide
WO2001085093A2 (en) * 1999-12-23 2001-11-15 Neurochem, Inc. Compounds and methods for modulating cerebral amyloid angiopathy
US20010047032A1 (en) * 1999-12-30 2001-11-29 Castillo Gerardo M. Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
KR100440370B1 (ko) * 2000-04-01 2004-07-19 (주)명문엘씨 2중 사출에 의한 밀폐용기 뚜껑
US6641801B1 (en) * 2000-04-03 2003-11-04 Love Lives Gargle method to reduce the duration of common cold symptoms
KR100359892B1 (ko) * 2000-04-21 2002-11-07 김미자 온라인 안경 조제 시스템 및 그 방법
JP4660026B2 (ja) * 2000-09-08 2011-03-30 パナソニック株式会社 表示パネルの駆動装置
US20070208087A1 (en) 2001-11-02 2007-09-06 Sanders Virginia J Compounds, compositions and methods for the treatment of inflammatory diseases
KR20020035987A (ko) * 2000-11-07 2002-05-16 백윤강 잣열매자동채취시스템
KR100427942B1 (ko) * 2001-09-05 2004-04-30 현대자동차주식회사 핀 연결 구조를 가진 인젝터 인슐레이션 플러그
KR100486365B1 (ko) * 2001-09-13 2005-04-29 주식회사 태평양 여성 갱년기 증후군 개선 효과를 갖는 조성물
KR100420594B1 (ko) * 2001-09-20 2004-03-02 병 목 이 태양 에너지의 복합 이용장치
KR20030026095A (ko) * 2001-09-24 2003-03-31 김덕교 요실금 수술을 위한 국소마취삽입기, 테이프, 테이프견인기구와 이들을 포함하는 외과수술장치
KR100444446B1 (ko) * 2001-09-29 2004-08-16 현대자동차주식회사 인젝션 노즐
KR20020000538A (ko) * 2001-12-05 2002-01-05 이정욱 이더넷을 이용한 무선로봇의 원격제어 시스템
KR100428181B1 (ko) * 2001-12-17 2004-04-28 현대자동차주식회사 디젤 엔진의 배기 재 순환 제어 장치 및 그 방법
KR20030050150A (ko) * 2001-12-18 2003-06-25 현대자동차주식회사 도로 상황 판정 시스템 및 그 방법
KR100427868B1 (ko) * 2001-12-18 2004-04-28 주식회사 백금정보통신 광대역 레이더 검출기 회로
AU2002360696A1 (en) * 2001-12-21 2003-07-30 Ilex Oncology, Inc. Combination comprising anti-cd52 antibodies and other therapeutic agents for treatment for multiple sclerosis
KR20030055648A (ko) * 2001-12-27 2003-07-04 이인영 금속판 절단용 커터
EP1820806A1 (de) * 2006-02-16 2007-08-22 Crossbeta Biosciences B.V. Affinitätsbereiche
PT2527315E (pt) * 2002-05-31 2014-06-24 Proteotech Inc Compostos, composições e métodos para o tratamento de doenças da amiloide e sinucleínopatias tais como doença de alzheimer, diabetes do tipo 2, e doença de parkinson
US20070003552A1 (en) * 2002-07-09 2007-01-04 Gebbink Martijn F B Cross-beta structure comprising amyloid binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fibril formation and for modulating cross-beta structure-mediated toxicity and method for interfering with blood coagulation
EP1380290A1 (de) * 2002-07-09 2004-01-14 Universitair Medisch Centrum Utrecht Cross-Beta-Strukturweg und seine therapeutische Relevanz
KR100438731B1 (ko) * 2002-07-27 2004-07-05 삼성전자주식회사 잉크 젯 노즐 상태에 따른 원고 인쇄 방법 및 장치
KR100452372B1 (ko) * 2002-07-29 2004-10-12 엘지전자 주식회사 건조기의 도어
KR100464732B1 (ko) * 2002-09-02 2005-01-05 에스케이텔레텍주식회사 회전형 안테나를 구비하는 폴더형 이동통신단말기
WO2004033448A2 (en) * 2002-10-11 2004-04-22 Proteotech, Inc. Isolation, purification and synthesis of procyanidin b2 and uses thereof
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
WO2005077382A1 (ja) * 2004-02-17 2005-08-25 National Institute Of Advanced Industrial Science And Technology プリオン増殖抑制剤
WO2006059252A2 (en) * 2004-11-12 2006-06-08 Neurochem (International) Limited Methods and fluorinated compositions for treating amyloid-related diseases
JP2008520647A (ja) * 2004-11-16 2008-06-19 ニューロケム （インターナショナル） リミテッド Ｃｎｓおよびアミロイド関連疾患治療のための化合物
CN101128421A (zh) 2004-12-22 2008-02-20 神经化学（国际）有限公司 治疗淀粉样相关疾病用的方法与组合物
WO2006083019A1 (ja) * 2005-02-03 2006-08-10 National University Corporation Nagoya University アミロイドβ蛋白凝集制御剤、アミロイドβ蛋白異常診断薬及びアミロイドβ蛋白異常診断薬キット
CA2615028A1 (en) * 2005-07-13 2007-01-18 Crossbeta Biosciences B.V. Cross-.beta. structure binding compounds
US8114832B2 (en) * 2005-07-13 2012-02-14 Crossbeta Biosciences B.V. Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition
CA2615020A1 (en) * 2005-07-13 2007-01-18 Crossbeta Biosciences B.V. Adjuvation through cross-.beta. structure
US20070015133A1 (en) * 2005-07-13 2007-01-18 Umc Utrecht Holding B.V. Method for detecting and/or removing protein and/or peptide comprising a cross-beta structure from an aqueous solution comprising a protein
US20090176736A1 (en) * 2006-04-20 2009-07-09 Katsumi Dohura Pharmaceutical composition for conformational diseases
WO2007137808A1 (en) * 2006-05-29 2007-12-06 University College Dublin, National University Of Ireland, Dublin Compositions comprising oligosaccharides for treating prion disease
JP5607930B2 (ja) 2006-10-12 2014-10-15 ビーエイチアイ リミテッド パートナーシップ ３−アミノ−１−プロパンスルホン酸を送達するための方法、化合物、組成物および媒体
EP2058001A1 (de) * 2007-11-08 2009-05-13 Crossbeta Biosciences B.V. Steigerung der Immunogenizität von Antigenen
EP2058000A1 (de) * 2007-11-08 2009-05-13 Crossbeta Biosciences B.V. Zur Aktivierung von T-Zellen fähige immunogene Zusammensetzung
JP2015526409A (ja) * 2012-07-03 2015-09-10 ヤンセン・サイエンシズ・アイルランド・ユーシー Ｃ−末端及び中心エピトープａ−ベータ抗体
WO2015184231A2 (en) * 2014-05-30 2015-12-03 Kolltan Pharmaceuticals, Inc. Regulators of anaplastic lymphoma kinase and uses thereof
EP3628315A1 (de) 2018-09-28 2020-04-01 Université de Caen Normandie Kombination aus acetylcholinesterase-inhibitor und 5-ht4-rezeptoragonist als neuroprotektives mittel zur behandlung von neurodegenerativen krankheiten

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110939A (en) * 1965-10-06 1968-04-24 Meito Sangyo Kk Sulphuric acid esters of disaccharides and hexitols,and their use as antipeptic ulcer agents
GB1381426A (en) * 1973-04-10 1975-01-22 Chugai Pharmaceutical Co Ltd Method of treating mammals and composition comprising oligosaccha ride sulphuric acid esters and nonionic surface active agents
US4098995A (en) * 1976-07-12 1978-07-04 American Cyanamid Company Polygalactosido-sucrose poly(h-)sulfate salts
US4912093A (en) * 1986-10-01 1990-03-27 Marion Laboratories, Inc. Use of synthetic sulfated saccharides to enhance wound healing
ZA869530B (en) * 1985-12-24 1987-10-28 Marion Laboratories Inc Use of synthetic sulfated saccharides to enhance wound healing
IT1205042B (it) * 1987-05-28 1989-03-10 Crinos Industria Farmaco Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer
JPH0347128A (ja) * 1989-07-13 1991-02-28 Chugai Pharmaceut Co Ltd 鼻粘膜保護剤
US5242932A (en) * 1991-12-17 1993-09-07 The Rockefeller University Treatment of amyloidosis associated with alzheimer disease
US5840294A (en) * 1993-03-29 1998-11-24 Queen's University At Kingston Method for treating amyloidosis
US5643562A (en) * 1993-03-29 1997-07-01 Queen's University Of Kingston Method for treating amyloidosis
US5388574A (en) * 1993-07-29 1995-02-14 Ingebrethsen; Bradley J. Aerosol delivery article
AUPN261895A0 (en) * 1995-04-28 1995-05-18 Australian National University, The Preparation and use of sulfated oligosaccharides
US5723589A (en) * 1995-12-21 1998-03-03 Icn Pharmaceuticals Carbohydrate conjugated bio-active compounds
EP1064013A4 (de) * 1998-03-13 2005-05-11 Univ Washington In vitro-bildung kongophiler amyloider plaques in form von malteser kreuzen zur identifizierung von antiplaque therapeutika zur behandlung von alzheimer- und prion erkrankungen

Also Published As

Publication number Publication date
EP1014996A1 (de) 2000-07-05
EP1014996A4 (de) 2000-10-11
DE69815122D1 (de) 2003-07-03
CA2301725C (en) 2008-11-18
EP1014996B1 (de) 2003-05-28
AU9125798A (en) 1999-03-16
DE69815122T2 (de) 2003-12-24
WO1999009999A1 (en) 1999-03-04
CA2301725A1 (en) 1999-03-04
ATE241365T1 (de) 2003-06-15
JP2001513569A (ja) 2001-09-04
ES2200366T3 (es) 2004-03-01
JP4659209B2 (ja) 2011-03-30
US6037327A (en) 2000-03-14

Similar Documents

Publication Publication Date Title
DK1014996T3 (da) Præparater indeholdende saccharid til behandling af Alzheimers sygdom og andre amyloidoser
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
DK1346041T3 (da) Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
NO20092874L (no) Forhindring og behandling av amyloidogen sykdom
MX9203543A (es) Medicamento.
DE69533040D1 (de) Medikamente zur vorbeugung oder behandlung von vaskulären hämorrhagien
IS1907B (is) Notkun klóbindiefnisins klíókínól við að framleiða lyfjablöndu til að meðhöndla Alzheimers-sjúkdóm
DK0690851T3 (da) Guanidin-derivater, som er anvendelige til behandling
RU92016463A (ru) Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе
IS3662A7 (is) Nýjar króman og thíókróman afleiður
PT1098643E (pt) Fenilacetilglutamina fenilacetilisoglutamina e/ou fenilacetato para o tratamento de doencas neoplasicas
DK0738147T3 (da) Anvendelse af riluzol ved behandling af mitochondriesygdomme
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
DE69729201D1 (de) Sulfonfluoride zur behandlung von der alzheimerischen krankheit
SE8804640D0 (sv) Medicament comprising cyclolinopeptide a
DK0642338T3 (da) Anvendelse af (E)-2-(p-fluorphenethyl)-3-fluorallylamin i behandlingen af Alzheimers sygdom
DK0703781T3 (da) Anvendelse af Efaroxan og derivater deraf til fremstilling af et lægemiddel til behandling af Parkinsons sygdom
DK0707477T3 (da) Anvendelse af Efaxoran og derivater deraf til fremstilling af lægemidler beregnet til behandling af neurodegenerative sygdo
HUP0004647A2 (hu) Glükóz-amino-glükánok alkalmazása diabétesszel társult szembetegségek kezelésére szolgáló gyógyszerkészítmények előállítására
NO961180L (no) Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom
EA199800941A1 (ru) Терапевтические средства, содержащие кислородные анион-радикалы и/или продукты их последующего превращения и расщепления, и их применение для лечения болезни паркинсона
KR920009403A (ko) 수면장해 치료용 이미다조벤조디아제핀
ATE178800T1 (de) Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung
RU93008438A (ru) Способ лечения острых респираторных заболеваний